UBS Group’s Biomea Fusion BMEA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEA
ACM
FISPB
UBS Group's BMEA Position: Q2 2026 in Review
UBS Group reduced its Biomea Fusion (BMEA) stake by 14% in Q2 2026, selling an estimated $106K and leaving 444,728 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #6068.
UBS Group first reported a position in BMEA in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.95M in Q1 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.
- UBS Group held 444,728 shares of Biomea Fusion worth $654K as of Q2 2026.
- UBS Group sold 70,827 Biomea Fusion shares in Q2 2026, an estimated $106K.
- Biomea Fusion made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6068 holding.
- UBS Group first reported a position in Biomea Fusion in Q3 2021 and has held it in 20 quarters since.
- UBS Group's Biomea Fusion position peaked at $3.95M in Q1 2024.
- 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.